Skip to main content
Top

Current Gastroenterology Reports

Issue 4/2019

Content (7 Articles)

Obesity Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao, Editor)

Obesity, Motility, Diet, and Intestinal Microbiota—Connecting the Dots

Maya Fayfman, Kristen Flint, Shanthi Srinivasan

Hepatitis B GI Oncology (R Bresalier, Section Editor)

The Epidemiology of Hepatocellular Carcinoma in the USA

Hyun-seok Kim, Hashem B. El-Serag

Magnetic Resonance Imaging Large Intestine (B Cash and R Chokshi, Section Editors)

Rectal Endoscopic Ultrasound in Clinical Practice

Stephen Hasak, Vladimir Kushnir

Irritable Bowel Syndrome Pediatric Gastroenterology (S Orenstein and S Khan, Section Editors)

Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease

Hannibal Person, Laurie Keefer

Endoscopy Stomach and Duodenum (J Pisegna and J Benhammou, Section Editors)

Gastric Neuroendocrine Tumors (Carcinoids)

Craig R. Gluckman, David C. Metz

Crohn's Disease Inflammatory Bowel Disease (S Hanauer, Section Editor)

Stem Cell Therapies for Inflammatory Bowel Disease

Amy L. Lightner

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine